| Literature DB >> 30258977 |
Arlene J Astell1,2,3, Sarah K Smith4, Stephen Potter4, Emily Preston-Jones4.
Abstract
INTRODUCTION: Group-based cognitive stimulation is the only nonpharmacologic intervention recommended by the UK National Institute for Clinical and Health Excellence for people with dementia. The potential of technology to extend the availability of group-based cognitive stimulation has not been tested.Entities:
Keywords: Cognition; Groups; Nonpharmacologic; Quality of life; Technology
Year: 2018 PMID: 30258977 PMCID: PMC6153376 DOI: 10.1016/j.trci.2018.08.003
Source DB: PubMed Journal: Alzheimers Dement (N Y) ISSN: 2352-8737
Fig. 1Flow of participants through the project. Abbreviation: CIRCA, Computer Interactive Reminiscence and Conversation Aid.
Mean scores on three outcome measures at baseline and postintervention for the CIRCA and CIRCA-WB groups
| Measure | CIRCA (N = 58) | CIRCA-WB (N = 85) | Significance |
|---|---|---|---|
| Age | 87.14 | 82.76 | .005 |
| Sex | |||
| Male (%) | 7 (12%) | 18 (21%) | |
| Female (%) | 51 (88%) | 67 (79%) | |
| Baseline | |||
| ACE-III | 46.55 | 46.9 | ns |
| QOL-AD | 31.12 | 32.4 | ns |
| EQ-5D | 62.41 | 64.96 | ns |
| Postintervention | |||
| ACE-III | 49.58 | 48.6 | ns |
| QOL-AD | 32.41 | 32.4 | ns |
| EQ-5D | 64.6 | 64.2 | ns |
Abbreviations: ACE-III, Addenbrooke's Cognitive Examination-III; CIRCA, Computer Interactive Reminiscence and Conversation Aid; CIRCA-WB, web-based version of CIRCA; QOL-AD, Quality of Life in Alzheimer's disease; EQ-5D, EuroQol five-dimensions scale.
Baseline scores of 143 participants who completed the intervention
| Characteristics | Total 143 |
|---|---|
| Mean age (y) | 84.43 |
| Sex | |
| Female (%) | 118 (82.5%) |
| Male (%) | 25 (17.5%) |
| Living situation | |
| At home (%) | 23 (16%) |
| Care home (%) | 120 (84%) |
| Previous information and communication technologies experience (%) | 6 (4%) |
Mean scores for 143 participants at baseline and postintervention
| Measure | Baseline ACE-III/100 (N = 143) | MMSE equivalent/30 | Post-CIRCA/100 (N = 143) | MMSE equivalent/30 | Change ACE-III | Change MMSE equivalent | % Improve | Significance |
|---|---|---|---|---|---|---|---|---|
| or same | ||||||||
| ACE-III | 46.76 | 15.51 | 49.0 | 16.33 | +2.24 | +0.82 | 59% | |
| 1.4% | ||||||||
| QOL-AD | 31.41 | 32.4 | +1 | 58% | ||||
| 5.6% | ||||||||
| EQ-5D | 63.67 | 64.36 | +0.69 | 44% | ns | |||
| 19.5% |
Abbreviations: ACE-III, Addenbrooke's Cognitive Examination-III; CIRCA, Computer Interactive Reminiscence and Conversation Aid; MMSE, Mini-Mental State Examination; EQ-5D, EuroQol five-dimensions scale; QoL-AD, Quality of Life in Alzheimer's disease.
Mean (standard deviation) scores for 42 participants tested at baseline, postintervention, and 3 months later
| Measure | Baseline | Post-CIRCA | 3-mo later |
|---|---|---|---|
| ACE-III | 48.73 | 50.66 | 52.35 |
| QOL-AD | 31.4 | 32.85 | 33.88 |
| EQ-5D | 64.16 | 65.92 | 68.61 |
Abbreviations: ACE-III, Addenbrooke's Cognitive Examination-III; CIRCA, Computer Interactive Reminiscence and Conversation Aid; EQ-5D, EuroQol five-dimensions scale; QoL-AD, Quality of Life in Alzheimer's disease.